News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
376,353 Results
Type
Article (14740)
Company Profile (116)
Press Release (361492)
Multimedia
Podcasts (50)
Webinars (9)
Section
Business (112800)
Career Advice (457)
Deals (18655)
Drug Delivery (41)
Drug Development (31274)
Employer Resources (51)
FDA (8839)
Job Trends (7696)
News (173072)
Policy (12401)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Standard (3)
Academia (1333)
Accelerated approval (10)
Allergies (71)
Alliances (34940)
ALS (42)
Alzheimer's disease (628)
Antibody-drug conjugate (ADC) (179)
Approvals (9043)
Artificial intelligence (444)
Autoimmune disease (61)
Automation (31)
Bankruptcy (131)
Best Places to Work (6520)
BIOSECURE Act (7)
Biosimilars (31)
Biotechnology (85)
Bladder cancer (62)
Brain cancer (27)
Breast cancer (262)
Cancer (2190)
Cardiovascular disease (149)
Career advice (416)
Career pathing (9)
CAR-T (200)
CDC (8)
Cell therapy (489)
Cervical cancer (21)
Clinical research (25884)
Collaboration (1232)
Compensation (230)
Complete response letters (8)
COVID-19 (1223)
CRISPR (85)
C-suite (481)
Cystic fibrosis (60)
Data (2637)
Decentralized trials (1)
Denatured (26)
Depression (43)
Diabetes (211)
Diagnostics (5145)
Digital health (36)
Diversity (7)
Diversity, equity & inclusion (9)
Drug discovery (163)
Drug pricing (19)
Drug shortages (4)
Duchenne muscular dystrophy (86)
Earnings (40526)
Editorial (9)
Employer branding (8)
Employer resources (45)
Events (53417)
Executive appointments (549)
FDA (10443)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (5)
Frontotemporal dementia (8)
Funding (897)
Gene editing (171)
Generative AI (38)
Gene therapy (345)
GLP-1 (302)
Government (1280)
Grass and pollen (3)
Guidances (220)
Healthcare (9917)
HIV (23)
Huntington's disease (13)
IgA nephropathy (26)
Immunology and inflammation (68)
Immuno-oncology (19)
Indications (50)
Infectious disease (1364)
Inflammatory bowel disease (81)
Inflation Reduction Act (5)
Influenza (73)
Intellectual property (151)
Interviews (52)
IPO (8060)
IRA (10)
Job creations (1438)
Job search strategy (363)
JPM (20)
Kidney cancer (6)
Labor market (24)
Layoffs (131)
Leadership (7)
Legal (2534)
Liver cancer (43)
Longevity (6)
Lung cancer (245)
Lymphoma (171)
Machine learning (34)
Management (18)
Manufacturing (524)
MASH (36)
Medical device (11843)
Medtech (11892)
Mergers & acquisitions (11229)
Metabolic disorders (399)
Multiple sclerosis (62)
NASH (3)
Neurodegenerative disease (120)
Neuropsychiatric disorders (19)
Neuroscience (1082)
NextGen: Class of 2026 (3537)
Non-profit (1533)
Now hiring (15)
Obesity (139)
Opinion (97)
Ovarian cancer (92)
Pain (105)
Pancreatic cancer (101)
Parkinson's disease (118)
Partnered (20)
Patents (301)
Patient recruitment (243)
Peanut (31)
People (33683)
Pharmaceutical (19)
Pharmacy benefit managers (3)
Phase 1 (9523)
Phase 2 (11629)
Phase 3 (7552)
Pipeline (2546)
Policy (59)
Postmarket research (502)
Preclinical (4282)
Press Release (66)
Prostate cancer (97)
Psychedelics (6)
Radiopharmaceuticals (177)
Rare diseases (300)
Real estate (3399)
Recruiting (22)
Regulatory (10376)
Reports (20)
Research institute (1301)
Resumes & cover letters (69)
Rett syndrome (21)
RNA editing (9)
RSV (40)
Schizophrenia (32)
Series A (162)
Series B (109)
Service/supplier (6)
Sickle cell disease (32)
Special edition (1)
Spinal muscular atrophy (60)
Sponsored (20)
Startups (2528)
State (2)
Stomach cancer (2)
Supply chain (48)
Tariffs (10)
The Weekly (23)
Vaccines (496)
Venture capital (43)
Weight loss (49)
Women's health (45)
Worklife (2)
Date
Today (5)
Last 7 days (274)
Last 30 days (1110)
Last 365 days (14676)
2026 (1396)
2025 (15034)
2024 (18708)
2023 (22102)
2022 (30818)
2021 (32523)
2020 (30547)
2019 (25797)
2018 (19460)
2017 (18874)
2016 (17764)
2015 (20561)
2014 (15177)
2013 (12742)
2012 (13781)
2011 (14070)
2010 (12829)
Location
Africa (325)
Alabama (69)
Alaska (6)
Arizona (178)
Arkansas (10)
Asia (24918)
Australia (4317)
California (5291)
Canada (1668)
China (547)
Colorado (284)
Connecticut (235)
Delaware (107)
Europe (50941)
Florida (906)
Georgia (219)
Hawaii (2)
Idaho (33)
Illinois (472)
India (33)
Indiana (263)
Iowa (8)
Japan (271)
Kansas (101)
Kentucky (15)
Louisiana (18)
Maine (22)
Maryland (718)
Massachusetts (3541)
Michigan (274)
Minnesota (407)
Mississippi (4)
Missouri (98)
Montana (27)
Nebraska (15)
Nevada (51)
New Hampshire (83)
New Jersey (1561)
New Mexico (18)
New York (1418)
North Carolina (758)
North Dakota (9)
Northern California (2241)
Ohio (169)
Oklahoma (16)
Oregon (24)
Pennsylvania (1010)
Puerto Rico (19)
Rhode Island (34)
South America (512)
South Carolina (60)
South Dakota (1)
Southern California (2268)
Tennessee (103)
Texas (876)
United States (19716)
Utah (193)
Vermont (1)
Virginia (90)
Washington D.C. (18)
Washington State (503)
West Virginia (3)
Wisconsin (87)
Wyoming (1)
376,353 Results for "biosig technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BioSig Technologies, Inc. Announces Corporate Rebrand to Streamex Corp.
September 11, 2025
·
3 min read
Press Releases
BioSig Technologies Inc. Announces Proposed Public Offering
August 13, 2025
·
4 min read
Press Releases
BioSig Technologies Inc. Announces Pricing of $15 Million Public Offering
August 13, 2025
·
4 min read
Press Releases
BioSig Technologies, Inc. & Streamex Announce Closing of $15 Million Public Offering
August 18, 2025
·
4 min read
Press Releases
BioSig Technologies Supplements Clarification on Recent Schedule 14A Filing. Closing of Merger with Streamex Exchange Corporation Not Affected
September 3, 2025
·
3 min read
Press Releases
BioSig Technologies Confirms Full Compliance with Nasdaq Requirements for Continued Listing on The Nasdaq Capital Market
March 27, 2025
·
4 min read
Pharm Country
BioSig Engages Consulting Firm for Business Model Strategies BAIPC will work to deploy a series of solutions to transform BioSig’s future course
BioSig Technologies, Inc. announced that it appointed Bridge Associates International Pharmaceutical Consulting to advise on business model strategies.
April 4, 2024
·
3 min read
Press Releases
BioSig Enters into an LOI to Merge with Streamex Exchange Corp.
May 6, 2025
·
4 min read
Business
BioSig Technologies Appoints Mr. Ferdinand Groenewald to Position of Interim Chief Financial Officer and Principal Accounting Officer
BioSig Technologies, Inc. or, a medical technology company delivering unprecedented accuracy and precision to intra-cardiac signal visualization, announced the appointment of Mr. Ferdinand Groenewald to the position of interim Chief Financial Officer.
June 10, 2024
·
4 min read
Business
BioSig Announces Reduction of its Workforce
BioSig Technologies, Inc., a medical technology company, announced that it has terminated a significant number of its employees and expects to substantially reduce business operations.
February 20, 2024
·
2 min read
1 of 37,636
Next
